IPO profile
Paras Healthcare Limited
PARASHLTH · NSE
- Price band
- ₹660 - ₹693
- Subscription
- 1.92x
Application & Issue Details
- Minimum Quantity
- 21 shares
- Minimum Application
- ₹14,553
- Issue Size
- Rs. 1450 Cr
- Face Value
- Not available
Company Overview
Paras Healthcare operates a network of multi-specialty tertiary care hospitals under the “Paras Health” brand, primarily focused on the healthcare markets of North India and East India. The company’s core business involves providing advanced healthcare services, including complex quaternary care and specialized therapeutic treatments. It manages eight operational hospitals across cities such as Gurugram, Patna, Panchkula, Ranchi, Udaipur, Srinagar, Darbhanga, and Kanpur, with a total bed capacity of 2,211 beds as of June 30, 2026. Paras Healthcare generates the majority of its revenue from in-patient department services, which include consultations, surgeries, and specialized treatments. The company’s revenue is heavily driven by six core clinical specialties: cardiac sciences, oncology, neurosciences, gastro sciences, orthopedics and sports injury, and renal sciences. Additionally, the company generates a smaller portion of its income through in-house pharmacy sales and outpatient consultations.
Important Dates
- Open Date
- 21 Oct 2026
- Close Date
- 23 Oct 2026
- Allotment Date
- Not available
- Listing Date
- 28 Oct 2026
Issue Timeline
- Issue open date
- Issue close date
- UPI mandate deadline
- Allotment finalization
- Refund initiation
- Share credit
- Listing date
- Mandate end date
- Lock-in end date for anchor investors (50%)
- Lock-in end date for anchor investors (remaining)
Grey Market Premium (GMP)
- Latest GMP
- +₹12
- GMP %
- +1.73%
- Quoted on
- 25 Oct 2026, 5:30 am
As of 25 Oct
Grey Market Premium (GMP) is unofficial and indicative. Actual listing price may differ.
Indicative Listing Estimate
- Est. Listing Price
- ₹705
- Est. Gain/Loss Per Share
- +₹12
- Est. Gain/Loss Per Lot
- +₹252
- Calculated On
- ₹693
Estimated listing price = upper price band + GMP. The final issue price is not yet known, so the upper end of the price band is assumed. Per-lot figures use 21 shares per lot. Indicative only: not a guaranteed listing price or profit, and excludes brokerage, taxes and charges.
Subscription
- QIB
- 2.86x
- NII
- 0.46x
- Retail
- 1.26x
- Total subscribed
- 1.92x
- Shares offered
- 1,20,83,331
- Shares bid
- 2,31,40,446
Updated 25 Oct 2026, 8:02 pm · source: nse
IPOAlerts subscription snapshot updated 24 Oct 2026, 11:00 pm.
Company Strengths & Risks
Reported strengths
- Established “Paras Health” brand in underserved North and East India markets.
- High revenue reliance on specialized CONGOR clinical programs.
- Diversified network of eight multi-specialty hospitals with 2,211 beds.
- Advanced quaternary care supported by modern medical infrastructure.
- Improved occupancy rates and a turnaround to profitability in Fiscal 2026.
Key risks
- High medical staff attrition may impact care quality.
- High revenue concentration in North India poses regional risks.
- Over-reliance on CONGOR specialties risks revenue drops.
- High debt of ₹9,394.67 million strains cash flows.
- Unregistered hospital leases risk eviction and disruption.
Company strengths and risks are informational summaries. Review the offer document for complete disclosures.
Documents & Coverage
IPO data last updated 25 Oct 2026, 8:02 pm IST · GMP: ipoalerts · subscription: nse
This page is for informational and educational purposes only. It is not investment advice and not a recommendation to buy, sell, or apply for this IPO. GMP and subscription figures are unofficial/may change. Please make your own independent decision.